Abstract
Chronic inflammation and oxidative stress play a pivotal role in the pathophysiology of most challenging illnesses, including cancer, Alzheimer’s, cardiovascular and autoimmune diseases. The present study aimed to investigate the anti-inflammatory potential of a new sulfadimethoxine derivative N-(4-(N-(2,6-dimethoxypyrimidin-4-yl) sulfamoyl) phenyl) dodecanamide (MHH-II-32). The compound was characterised by applying 1H-, 13C-NMR, EI–MS and HRFAB–MS spectroscopic techniques. The compound inhibited zymosan-induced oxidative bursts from whole blood phagocytes and isolated polymorphonuclear cells with an IC50 value of (2.5 ± 0.4 and 3.4 ± 0.3 µg/mL), respectively. Furthermore, the inhibition of nitric oxide with an IC50 (3.6 ± 2.2 µg/mL) from lipopolysaccharide-induced J774.2 macrophages indicates its in vitro anti-inflammatory efficacy. The compound did not show toxicity towards normal fibroblast cells. The observational findings, gross anatomical analysis of visceral organs and serological tests revealed the non-toxicity of the compound at the highest tested intraperitoneal (IP) dose of 100 mg/kg in acute toxicological studies in Balb/c mice. The compound treatment (100 mg/kg) (SC) significantly (P < 0.001) downregulated the mRNA expression of inflammatory markers TNF-α, IL-1β, IL-2, IL-13, and NF-κB, which were elevated in zymosan-induced generalised inflammation (IP) in Balb/c mice while upregulated the expression of anti-inflammatory cytokine IL-10, which was reduced in zymosan-treated mice. No suppressive effect was observed at the dose of 25 mg/kg. Ibuprofen was taken as a standard drug. The results revealed that the new acyl derivative of sulfadimethoxine has an immunomodulatory effect against generalised inflammatory response with non-toxicity both in vitro and in vivo, and has therapeutic potential for various chronic inflammatory illnesses.
Similar content being viewed by others
Data availability
The data will be available from the corresponding author upon reasonable request.
Abbreviations
- ANOVA:
-
Analysis of variance
- BME:
-
β-mercaptoethanol
- cDNA:
-
Complementary deoxyribonucleic acid
- CVDs:
-
Cardiovascular diseases
- DMEM:
-
Dulbecco’s-modified eagle’s medium
- DNA:
-
Deoxyribonucleic acid
- dNTPs:
-
Deoxynucleotide triphosphate
- EDTA:
-
Ethylene diamine tetra acetic acid
- FBS:
-
Fetal bovine serum
- ESRD:
-
End-stage renal disease
- GPx:
-
Glutathione peroxidase
- HBSS:
-
Hank’s balance salt solution
- IBD:
-
Inflammatory bowel disease
- IC50:
-
Inhibitory concentration 50
- IL:
-
Interleukin
- IP:
-
Intraperitoneal
- L-NMMA:
-
NG-monomethyl-l-arginine acetate
- LPS:
-
Lipopolysaccharide
- LSM:
-
Lymphocyte separation medium
- MTT:
-
Methyl thiazolyl tetrazolium
- MAPK:
-
Mitogen-activated protein kinase
- NADPH:
-
Nicotinamide adenine dinucleotide phosphate (reduced)
- NF-кB:
-
Nuclear factor kappa B
- NO:
-
Nitric oxide
- NOS:
-
Nitric oxide synthase
- PBS:
-
Phosphate buffer saline
- PCR:
-
Polymerase chain reaction
- PMNs:
-
Polymorphonuclear leukocytes
- RA:
-
Rheumatoid arthritis
- RBCs:
-
Red blood cells
- RLU:
-
Relative light unit
- RNA:
-
Ribonucleic acid
- ROS:
-
Reactive oxygen species
- SC:
-
Subcutaneous
- SLE:
-
Systematic lupus erythematosus
- ZIGI:
-
Zymosan-induced generalised inflammation
- SD:
-
Standard deviation
- SEM:
-
Standard error of mean
- SOZ:
-
Serum opsonized zymosan
- SPSS:
-
Statistical package for social sciences
- TNF-α:
-
Tumor necrosis factor alpha
- NS:
-
Nephrotic syndrome
- NSAIDs:
-
Nonsteroidal anti-inflammatory drugs
References
Adams V et al (2002) Induction of iNOS expression in skeletal muscle by IL-1β and NFκB activation: an in vitro and in vivo study. Cardiovasc Res 54(1):95–104
Akdis CA et al (2020) Type 2 immunity in the skin and lungs. Allergy 75(7):1582–1605
Akhter E, Bilal S, Haque U (2011) Prevalence of arthritis in India and Pakistan: a review. Rheumatol Int 31(7):849–855
Al-Khalaifah H, Al-Nasser A (2018) Immune response of molluscs. In: Molluscs. IntechOpen. https://doi.org/10.5772/intechopen.81778
Amale MH, Shahneh A, Nasrollahi S (2013) Effects of nitric oxide synthase inhibition on goat oocyte meiotic maturation. Arch Anim Breed 56(1):255–263
Bertsias G, Cervera R, Boumpas DT (2012) Systemic lupus erythematosus: pathogenesis and clinical features. EULAR Textb Rheum Dis 5:476–505
Bonizzi G, Karin M (2004) The two NF-κB activation pathways and their role in innate and adaptive immunity. Trends Immunol 25(6):280–288
Bouillaud F (2023) Inhibition of succinate dehydrogenase by pesticides (SDHIs) and energy metabolism. Int J Mol Sci 24(4):4045
Chromý V, Rozkošná K, Sedlak P (2008) Determination of serum creatinine by Jaffe method and how to calibrate to eliminate matrix interference problems. Clin Chem Lab Med 46(8):1127–1133
Courtois G, Gilmore T (2006) Mutations in the NF-κB signaling pathway: implications for human disease. Oncogene 25(51):6831
Danihelová M et al (2013) Antioxidant action and cytotoxicity on HeLa and NIH-3T3 cells of new quercetin derivatives. Interdiscip Toxicol 6(4):209–216
Ertel W et al (1992) Ibuprofen restores cellular immunity and decreases susceptibility to sepsis following hemorrhage. J Surg Res 53(1):55–61
Fenton KA, Pedersen HL (2023) Advanced methods and novel biomarkers in autoimmune diseases‑a review of the recent years progress in systemic lupus erythematosus. Front Med 10:1183535. https://doi.org/10.3389/fmed.2023.1183535
Fischer R, Maier O (2015) Interrelation of oxidative stress and inflammation in neurodegenerative disease: role of TNF. Oxid Med Cell Longev 2015:610813. https://doi.org/10.1155/2015/610813
Garthwaite J (2016) From synaptically localized to volume transmission by nitric oxide. J Physiol 594(1):9–18
Ghosh M et al (2015) The interplay between cyclic AMP, MAPK, and NF-κB pathways in response to proinflammatory signals in microglia. BioMed Res Int 2015:308461. https://doi.org/10.1155/2015/308461
Hämäläinen M et al (2007) Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-κB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-κB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediat Inflam 2007:45673. https://doi.org/10.1155/2007/45673
Haroon N et al (2007) Impact of rheumatoid arthritis on quality of life. Mod Rheumatol 17(4):290–295
Hiraku Y et al (2010) The role of iNOS-mediated DNA damage in infection-and asbestos-induced carcinogenesis. Ann N Y Acad Sci 1203(1):15–22
Hwang JH et al (2012) Susceptibility to gold nanoparticle-induced hepatotoxicity is enhanced in a mouse model of nonalcoholic steatohepatitis. Toxicology 294(1):27–35
Karin M, Greten FR (2005) NF-κB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5(10):749
Kayser V, Besson J, Guilbaud G (1987) Paradoxical hyperalgesic effect of exceedingly low doses of systemic morphine in an animal model of persistent pain (Freund’s adjuvant-induced arthritic rats). Brain Res 414(1):155–157
Khan H et al (2010) The antinociceptive activity of Polygonatumverticillatum rhizomes in pain models. J Ethnopharmacol 127(2):521–527
Koeberle A, Werz O (2014) Multi-target approach for natural products in inflammation. Drug Discovery Today 19(12):1871–1882
Kohen R, Nyska A (2002) Invited review: Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol Pathol 30(6):620–650
Koko W et al (2008) In vitro immunomodulating properties of selected Sudanese medicinal plants. J Ethnopharmacol 118(1):26–34
Kunwar A, Priyadarsini K (2011) Free radicals, oxidative stress and importance of antioxidants in human health. J Med Allied Sci 1(2):53–60
Libby P (2007) Inflammatory mechanisms: the molecular basis of inflammation and disease. Nutr Rev 65(suppl_3):S140–S146
McInnes IB, Schett G (2011) The pathogenesis of rheumatoid arthritis. N Engl J Med 365(23):2205–2219
Murata A et al (2003) A novel inhibitory effect of D-allose on production of reactive oxygen species from neutrophils. J Biosci Bioeng 96(1):89–91
Murray PJ (2005) The primary mechanism of the IL-10-regulated antiinflammatory response is to selectively inhibit transcription. Proc Natl Acad Sci 102(24):8686–8691
Murray PJ (2006) Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-inflammatory response. Curr Opin Pharmacol 6(4):379–386
Oray M et al (2016) Long-term side effects of glucocorticoids. Expert Opin Drug Saf 15(4):457–465
Rampton DS (1998) New treatments for inflammatory bowel disease. World J Gastroenterol 4(5):369
Rizvi F et al (2019) Studies on isoniazid derivatives through a medicinal chemistry approach for the identification of new inhibitors of urease and inflammatory markers. Sci Rep 9(1):1–14
Salama RA et al (2016) Equivalent intraperitoneal doses of ibuprofen supplemented in drinking water or in diet: a behavioral and biochemical assay using antinociceptive and thromboxane inhibitory dose–response curves in mice. PeerJ 4:e2239
Shah S et al (2018) Diclofenac 1, 3, 4-oxadiazole derivatives; biology-oriented drug synthesis (BIODS) in search of better non-steroidal, non-acid antiinflammatory agents. Med Chem 14(7):674–687
Shahriari S et al (2011) Effect of ibuprofen on IL-1 [Beta], TNF-[alpha] and PGE2 levels in periapical exudates: a double blinded clinical trial. Iran J Immunol 8(3):176
Shinde A, Ganu J, Naik P (2012) Effect of free radicals & antioxidants on oxidative stress: a review. J Dent Allied Sci 1(2):63
Siddiqui H et al (2018) Sulphamethazine derivatives as immunomodulating agents: new therapeutic strategies for inflammatory diseases. PLoS ONE 13(12):e0208933
Siddiqui H et al (2021) Synthesis of new enrofloxacin derivatives as potential antibiofilm drugs against staphylococcus aureus and klebsiella pneumoniae. Med Chem 17(1):85–96
Sies H, Jones DP (2020) Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nat Rev Mol Cell Biol 21(7):363–383
Tafani M et al (2013) Modulators of HIF1α and NFkB in cancer treatment: is it a rational approach for controlling malignant progression? Front Pharmacol 4:13
Vallabhapurapu S, Karin M (2009) Regulation and function of NF-κB transcription factors in the immune system. Annu Rev Immunol 27:693–733
Vella L et al (2014) Ibuprofen supplementation and its effects on NF-κB activation in skeletal muscle following resistance exercise. Physiol Rep 2(10):e12172
Volman TJ, Hendriks T, Goris RJA (2005) Zymosan-induced generalised inflammation: experimental studies into mechanisms leading to multiple organ dysfunction syndrome. Shock 23(4):291–297
Wajant H, Pfizenmaier K, Scheurich P (2003) Tumor necrosis factor signaling. Cell Death Differ 10(1):45
Weng T-C et al (2011) Ibuprofen worsens Streptococcus pyogenes soft tissue infections in mice. J Microbiol Immunol Infect 44(6):418–423
Wong C et al (2005) Role of p38 MAPK and NF-kB for chemokine release in coculture of human eosinophils and bronchial epithelial cells. Clin Exp Immunol 139(1):90–100
Wynn TA (2003) IL-13 effector functions. Annu Rev Immunol 21(1):425–456
Yang D, Jones KS (2009) Effect of alginate on innate immune activation of macrophages. J Biomed Mater Res Part A 90(2):411–418
Yang YM, Seki E (2015) TNFα in liver fibrosis. Curr Pathobiol Rep 3(4):253–261
Acknowledgements
We are thankful to Animal house facility of PCMD, ICCBS, University of Karachi for providing desired strain of mice and proper work station. Biobank facility of PCMD, ICCBS, University of Karachi provided us cell lines. HMH is thankful to the International Center for Chemical and Biological Sciences (ICCBS), University of Karachi, Pakistan for the 1-year doctoral fellowship under supervision of HS.
Funding
The work is financially supported by Higher Education commission (HEC), Pakistan (Project No. 8263 NRPU 2017–18).
Author information
Authors and Affiliations
Contributions
TA conducted biology experiments, collected and analysed the underlying data, provide statistical analysis. TA and SFS drafted the manuscript. HMH performed chemistry experiments synthesize and provide compound for biological studies and analysed data under the supervision of HS. AJ contributed to the concept and design of the current study, analysed the biological data and interpreted the results together with TA. AJ supervised the biology experiments, responsible for fund support and revised and finalized the manuscript. All authors read and approved the submitted version of this article.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there were no conflicts of interest.
Ethical approval
The in vitro studies on human blood cells was conducted as per approval of the Independent Ethics Committee, UoK No: ICCBS/IEC-008-BC-2015. The blood was collected from healthy volunteers with their informed consent, for in vivo studies animal study protocol was approved by the local ethical committee of research animals, PCMD, ICCBS, UK (ASP No. 2018–0010).
Consent for publication
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Baig, T.A., Haniffa, H.M., Siddiqui, H. et al. A new acyl derivative of sulfadimethoxine inhibits phagocyte oxidative burst and ameliorates inflammation in a mice model of zymosan-induced generalised inflammation. Inflammopharmacol 31, 3303–3316 (2023). https://doi.org/10.1007/s10787-023-01372-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10787-023-01372-0